<p>A, Western blot analysis showing the expression of pEGFR, EGFR, pHER2, HER2, pHER3, HER3, pc-Met, c-Met, PTEN, pAkt, Akt, pERK1/2, and ERK1/2 proteins, and α-tubulin as a loading control. B, Exponentially growing PC9 and PC9/ER1 cells were exposed to various doses of erlotinib for 5 hr, and followed by Western blot analysis. C, Exponentially growing 11–18, 11–18/ER1-7, and 11–18/ER2-1 cells were exposed to various doses of erlotinib for 5 hr, and followed by Western blot analysis.</p
<p>Real-time RT-PCR for genes encoding fibrogenic molecules (a), proinflammatory cytokines (b), apop...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib, 100 nM erlotinib or 100 ug/...
<p><b>A–B</b>, Protein lysates from HCC827 (A) and HCC4006 (B) cells treated with DMSO (vehicle) or ...
<p>A. EGFR is autophosphorylated in ER H2170 and downregulated in H358-E4 resistant cell lines. p-mT...
<p>A) Representative western blots with EGFR and ERK1/2 antibodies and B) pEGFR (Y1068) and pERK1/2 ...
<p>Western blotting of 8% SDS-PAGE of parental and ERL-resistant HCC827 cells treated with ERL (erlo...
<p>A, Exponentially growing PC9 and PC9/ER1 cells were exposed to various doses of erlotinib for 5 h...
Erlotinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has b...
<p>A, PC9/ER1 cells were treated with or without 1 µM erlotinib, and 5 µM lapatinib for 5 hrs, and f...
<p>A. In SR H2170 cells, HGF induced pronounced p-ERK signaling compared to parental cells. Cells we...
<p><i>A</i>, Tu212 and Tu686 cells were treated with erlotinib (0.1µM) for various times. Levels of ...
<p>(A) The indicated human glioma cell lines were harvested and the expression levels of the indicat...
<p>Head and neck (with PC-3 as prostate), bladder, and lung were treated with indicated doses of erl...
<p>The erlotinib sensitive cell lines HCC827 and PC9 and the erlotinib-resistant cell line H1975 wer...
<p>H1975, H2170-ER and H2170-SR cells were plated at 125,000 cells per dish in 35 mm dishes and star...
<p>Real-time RT-PCR for genes encoding fibrogenic molecules (a), proinflammatory cytokines (b), apop...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib, 100 nM erlotinib or 100 ug/...
<p><b>A–B</b>, Protein lysates from HCC827 (A) and HCC4006 (B) cells treated with DMSO (vehicle) or ...
<p>A. EGFR is autophosphorylated in ER H2170 and downregulated in H358-E4 resistant cell lines. p-mT...
<p>A) Representative western blots with EGFR and ERK1/2 antibodies and B) pEGFR (Y1068) and pERK1/2 ...
<p>Western blotting of 8% SDS-PAGE of parental and ERL-resistant HCC827 cells treated with ERL (erlo...
<p>A, Exponentially growing PC9 and PC9/ER1 cells were exposed to various doses of erlotinib for 5 h...
Erlotinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has b...
<p>A, PC9/ER1 cells were treated with or without 1 µM erlotinib, and 5 µM lapatinib for 5 hrs, and f...
<p>A. In SR H2170 cells, HGF induced pronounced p-ERK signaling compared to parental cells. Cells we...
<p><i>A</i>, Tu212 and Tu686 cells were treated with erlotinib (0.1µM) for various times. Levels of ...
<p>(A) The indicated human glioma cell lines were harvested and the expression levels of the indicat...
<p>Head and neck (with PC-3 as prostate), bladder, and lung were treated with indicated doses of erl...
<p>The erlotinib sensitive cell lines HCC827 and PC9 and the erlotinib-resistant cell line H1975 wer...
<p>H1975, H2170-ER and H2170-SR cells were plated at 125,000 cells per dish in 35 mm dishes and star...
<p>Real-time RT-PCR for genes encoding fibrogenic molecules (a), proinflammatory cytokines (b), apop...
<p>Cells were cultured to log-phase and treated with 100 nM dacomitinib, 100 nM erlotinib or 100 ug/...
<p><b>A–B</b>, Protein lysates from HCC827 (A) and HCC4006 (B) cells treated with DMSO (vehicle) or ...